Transcriptomics

Dataset Information

0

Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop [SmartSeq2]


ABSTRACT: The lack of T cell infiltrates is a major obstacle to effective immunotherapy in cancer. Conversely, the formation of tumor-associated tertiary-lymphoid-like structures (TA-TLLSs), which are the local site of humoral and cellular immune responses against cancers, is associated with good prognosis, and they have recently been detected in immune checkpoint blockade (ICB)-responding patients. However, how these lymphoid aggregates develop remains poorly understood. By employing single-cell transcriptomics, endothelial fate mapping, and functional multiplex immune profiling, we demonstrate that antiangiogenic immune-modulating therapies evoke transdifferentiation of postcapillary venules into inflamed high-endothelial venules (HEVs) via lymphotoxin/lymphotoxin beta receptor (LT/LTβR) signaling. In turn, tumor HEVs boost intratumoral lymphocyte influx and foster permissive lymphocyte niches for PD1- and PD1+TCF1+ CD8 T cell progenitors that differentiate into GrzB+PD1+ CD8 T effector cells. Tumor-HEVs require continuous CD8 and NK cell-derived signals revealing that tumor HEV maintenance is actively sculpted by the adaptive immune system through a feed-forward loop.

ORGANISM(S): Mus musculus

PROVIDER: GSE198069 | GEO | 2022/11/02

REPOSITORIES: GEO

Similar Datasets

2022-11-02 | GSE198079 | GEO
2019-03-12 | GSE106514 | GEO
2022-03-31 | GSE196703 | GEO
2022-03-03 | GSE197559 | GEO
2021-12-14 | GSE154898 | GEO
2021-09-01 | GSE157669 | GEO
2023-02-14 | GSE224483 | GEO
2023-02-14 | GSE224315 | GEO
2023-02-14 | GSE224023 | GEO
2014-08-31 | E-GEOD-58056 | biostudies-arrayexpress